Ontology type: schema:ScholarlyArticle Open Access: True
2001-11
AUTHORSRJ Morgan, JH Doroshow, L Leong, J Schriber, S Shibata, S Forman, V Hamasaki, K Margolin, G Somlo, J Alvarnas, M McNamara, J Longmate, J Raschko, W Chow, S Vasilev, K McGonigle, Y Yen
ABSTRACTThis study was performed in order to evaluate the toxicities, progression-free and overall survival of patients with responsive residual or recurrent ovarian cancer treated with high-dose chemotherapy. Twenty-seven patients were treated. Doxorubicin, 165 mg/m(2) over 96 h (days -12 to -8), etoposide 700 mg/m(2) every day x3 (days -6 to -4), and cyclophosphamide 4.2 g/m(2) on d -3 was followed by stem cells and granulocyte colony-stimulating factor. The median days of granulocyte count <500/microl was 14 (range 10-42) and platelets <20,000/microl was 13 (range 2-80). Median numbers of red cell and platelet transfusions were 15 (5-16) and 14 (4-103). Toxicity included mucositis requiring narcotic analgesia in all patients. Asymptomatic decreases in ejection fraction to values <50% were observed in four patients. No clinical congestive heart failure was observed. One death due to sepsis was observed. Median progression-free survival is 7.5 months (1.0-56 months); five patients remain alive, two of whom remain progression-free at 19.5 and 24.5 months post transplant. Median overall survival is 14.0 months (1-68 months). We conclude that high-dose anthracyclines may be safely administered to ovarian cancer patients. The short overall and progression-free survivals observed in our population suggest that this combination is not optimal. More... »
PAGES859
http://scigraph.springernature.com/pub.10.1038/sj.bmt.1703243
DOIhttp://dx.doi.org/10.1038/sj.bmt.1703243
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1013262824
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/11781646
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "CA-125 Antigen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Carcinoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Combined Modality Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cyclophosphamide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease-Free Survival",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Doxorubicin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Etoposide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematopoietic Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Proteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ovarian Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ovariectomy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Survival Analysis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation, Autologous",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Failure",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Morgan",
"givenName": "RJ",
"id": "sg:person.012661132562.89",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012661132562.89"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Doroshow",
"givenName": "JH",
"id": "sg:person.01135535666.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135535666.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Leong",
"givenName": "L",
"id": "sg:person.0710670347.86",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710670347.86"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"City of Hope/Samaritan Bone Marrow Transplant Program, Phoenix, AZ, USA"
],
"type": "Organization"
},
"familyName": "Schriber",
"givenName": "J",
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Shibata",
"givenName": "S",
"id": "sg:person.01137520410.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137520410.90"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Forman",
"givenName": "S",
"id": "sg:person.015413464732.83",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015413464732.83"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Hamasaki",
"givenName": "V",
"id": "sg:person.01205633610.20",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205633610.20"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Margolin",
"givenName": "K",
"id": "sg:person.0646721507.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646721507.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Somlo",
"givenName": "G",
"id": "sg:person.01121216740.00",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121216740.00"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"City of Hope/Samaritan Bone Marrow Transplant Program, Phoenix, AZ, USA"
],
"type": "Organization"
},
"familyName": "Alvarnas",
"givenName": "J",
"id": "sg:person.01320032157.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320032157.33"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "McNamara",
"givenName": "M",
"id": "sg:person.01222034710.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222034710.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Biostatistics, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Longmate",
"givenName": "J",
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Raschko",
"givenName": "J",
"id": "sg:person.0652562607.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652562607.07"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Chow",
"givenName": "W",
"id": "sg:person.0644647751.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644647751.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Gynecologic Oncology, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Vasilev",
"givenName": "S",
"id": "sg:person.01103237607.92",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103237607.92"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Gynecologic Oncology, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "McGonigle",
"givenName": "K",
"id": "sg:person.01117277533.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117277533.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "City Of Hope National Medical Center",
"id": "https://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Yen",
"givenName": "Y",
"id": "sg:person.0760103773.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760103773.19"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1002/1097-0142(19940315)73:6<1678::aid-cncr2820730621>3.0.co;2-u",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019447081"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/07357909709039727",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019545303"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/(sici)1097-0142(19990401)85:7<1555::aid-cncr17>3.0.co;2-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021306481"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199612263352603",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025944436"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0090-8258(87)90257-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027753287"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0277-5379(89)90199-5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035372832"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0090-8258(88)90300-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044398846"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199601043340101",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049279167"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejm199311183292108",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050091583"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/01621459.1958.10501452",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1058299418"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1992.10.5.706",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1077003810"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1992.10.5.718",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1077003811"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1078684834",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1987.5.10.1607",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078843415"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1989.7.4.457",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079457130"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1079520974",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1987.5.8.1157",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079562424"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1987.5.5.756",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1079828705"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1995.13.3.726",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1082550221"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1993.11.8.1583",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1082651523"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083012278",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083051140",
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1997.15.4.1302",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083105849"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1997.15.4.1309",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083105850"
],
"type": "CreativeWork"
}
],
"datePublished": "2001-11",
"datePublishedReg": "2001-11-01",
"description": "This study was performed in order to evaluate the toxicities, progression-free and overall survival of patients with responsive residual or recurrent ovarian cancer treated with high-dose chemotherapy. Twenty-seven patients were treated. Doxorubicin, 165 mg/m(2) over 96 h (days -12 to -8), etoposide 700 mg/m(2) every day x3 (days -6 to -4), and cyclophosphamide 4.2 g/m(2) on d -3 was followed by stem cells and granulocyte colony-stimulating factor. The median days of granulocyte count <500/microl was 14 (range 10-42) and platelets <20,000/microl was 13 (range 2-80). Median numbers of red cell and platelet transfusions were 15 (5-16) and 14 (4-103). Toxicity included mucositis requiring narcotic analgesia in all patients. Asymptomatic decreases in ejection fraction to values <50% were observed in four patients. No clinical congestive heart failure was observed. One death due to sepsis was observed. Median progression-free survival is 7.5 months (1.0-56 months); five patients remain alive, two of whom remain progression-free at 19.5 and 24.5 months post transplant. Median overall survival is 14.0 months (1-68 months). We conclude that high-dose anthracyclines may be safely administered to ovarian cancer patients. The short overall and progression-free survivals observed in our population suggest that this combination is not optimal.",
"genre": "research_article",
"id": "sg:pub.10.1038/sj.bmt.1703243",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2688694",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2438845",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1096890",
"issn": [
"0268-3369",
"1476-5365"
],
"name": "Bone Marrow Transplantation",
"type": "Periodical"
},
{
"issueNumber": "9",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "28"
}
],
"name": "Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer",
"pagination": "859",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"3f2ecc51050cd2f2d1e7091d716833b917df215414a28c2906fb4af7ed12a54d"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"11781646"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8702459"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/sj.bmt.1703243"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1013262824"
]
}
],
"sameAs": [
"https://doi.org/10.1038/sj.bmt.1703243",
"https://app.dimensions.ai/details/publication/pub.1013262824"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T16:28",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000422.jsonl",
"type": "ScholarlyArticle",
"url": "https://www.nature.com/articles/1703243"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703243'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703243'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703243'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703243'
This table displays all metadata directly associated to this object as RDF triples.
345 TRIPLES
21 PREDICATES
75 URIs
43 LITERALS
31 BLANK NODES